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ABSTRACT 
 
The Association between Health Financing and Maternal and Child 
Health in Middle East and North Africa Countries 
 
Ahmed Abdelgawad 
 
Improving maternal and child health outcomes for women and children is a critical step to 
achieve the MDGs; however it requires sufficient funding to implement proven quality 
interventions. The aim of the study is to investigate the relationship between the different health 
care financing options cross the Middle East and North Africa “MENA” countries and the 
maternal and child health outcomes. Our main argument is that: Can different health care 
financing strategies affect Maternal, Neonatal and Child health?  If yes, How?. This study is 
based on a cross sectional analysis of twenty one states from MENA region between 2009 and 
2013 exploring the three dimensions of the maternal and child health outcomes namely a) Infant 
mortality b) Maternal mortality and c) Child health. Correlation between financial and maternal 
and child health indicators as well as linear regressions was carried out to investigate the 
relationships between the maternal and child health indicators and health spending consequently 
health system financing strategy. The findings of this study indicate that more spending on health 
is highly associated with positive maternal and child health outcomes namely reduction in infant 
and child mortality. Our results also indicate that the improvements in government effectiveness 
in regards to  government health spending is accompanied with higher maternal and child health 
outcomes. Thus, increasing government expenditures is likely to lead to better improvements of 
health outcomes if it is accompanied by the right policies and institutions, which was the case of 
the first group of countries in MENA region.  
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Introduction 
 
The health for the person is one of the most important treasures for his life. There is 
always a debate on health care services provided for people in developing countries in terms of 
the quality and affordability.  
Improving maternal and child health outcomes for women and children is critical step to 
achieve the MDGs; however it requires sufficient funding, polices to implement quality 
interventions that can support the process from pre-pregnancy to the delivery even after delivery 
during the postnatal care period as well as the childhood to the adulthood by scaling those 
interventions on wider scales. The access to and utilization of health services are considered one 
of the main challenges towards a quality health care systems of the MENA region, however it is 
clear that many Arab countries have witnessed marked improvements in the health status of their 
population over the past few decades, as evidenced by economic, social and health indicators. 
(UNDP 2012)  
Within the framework of WHO definition of health as a state of complete physical, 
mental and social well-being, and not merely the absence of disease or infirmity, the 
reproductive health addresses the reproductive processes, functions and system at all stages of 
life. Reproductive health, therefore, implies that people are able to have a responsible, satisfying 
and safe sexual life and that they have the capability to reproduce and the freedom to decide if, 
when and how often to do so. Implicit in this are the right of men and women to be informed of 
and to have access to safe, effective, affordable and acceptable methods of fertility regulation of 
their choice, and the right of access to appropriate health care services that enable women to go 
safely through the whole process from the pregnancy till delivery with best outcomes for the 
couple and the infant (WHO 2007). 
8 
 
Improving maternal and child health outcomes which includes maternal, child and 
neonatal indicators is critical step to achieve the MDGs. However it requires sufficient funding 
to finance the health system to implement proven quality interventions that span the continuum 
of care from pre-pregnancy to delivery, the postnatal period, and childhood additionally scaling 
those interventions on wider scales. This framework pointed the relationship between the RH 
outcomes and the spending strategy. The external environment for this relationship emphasis that 
the access to and utilization of health services are considered one of the main challenges 
concerns to the health care systems. 
The aim of the study is to investigate the relationship between the different health care 
financing options cross the Middle East and North Africa “MENA” countries and the maternal 
and child health outcomes among those countries.   
The overwhelming majority of the cross-country studies (especially studies of developing 
countries) use cross-sectional datasets to explore this question of effectiveness of health 
spending.  So our research question start with the frame work of “Spending on health care 
services matter in achieving better health outcomes” However, our understanding of this issue 
would benefit greatly from using a dataset for MENA region and adequately controlling for 
country specific effects, which has rarely been done in the literature due to the unavailability of 
panel data.  
 
So the author conducted a cross sectional analysis of 21 states from MENA region which 
are countries of the Eastern Mediterranean Region of the WHO during the last five years 2009 to 
2013 exploring the three dimensions of the maternal and child health outcomes namely a) Infant 
mortality b) Maternal mortality and c) Child health. Our unified source of data was the WHO 
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Eastern Mediterranean Region Countries statistics summaries sheets which include all data 
needed available for each country from 2009 till 2013. 
In 2012 the countries of the Region were categorized into three groups based on their 
health financing system. We used the WHO grouping system for countries of the Eastern 
Mediterranean region which is supported by the World Bank classification of MENA countries 
into low, lower middle, upper middle and high income levels. Control variables include data out 
of the following maternal and child health outcomes “total fertility rate, contraceptive 
prevalence, maternal mortality ratio, antenatal care coverage, births attended by skilled health 
personnel, availability of basic essential obstetric care and availability of comprehensive 
essential obstetric care, perinatal mortality rate, prevalence of low birth weight, prevalence of 
positive syphilis serology in pregnant women, prevalence of anemia in women, reported 
prevalence of women with genital mutilation, prevalence of infertility.    
The methodology relies on correlation and linear regressions to identify the crude 
relationships between each independent variable and spending.  
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Health care in MEAN region .. Challenges and opportunities  
 
Over the last decades there are many concerns related to heath equity and social 
determinants of health. Those concerns pushed the policy makers to think of factors that can help 
in drafting policies and actions that tackle the health structural and social determinants. (Shah et 
al., 2007) 
 There is a huge attention given to the area of maternal health research, to examine the 
socioeconomic maternal health inequities and disparities. So numerous studies in the 
international literature have investigated various dimensions of maternal health inequities and 
confirmed that there is a strong relationship between women's socioeconomic status and their 
maternal health indicators, in which low socioeconomic status is significantly associated with 
low maternal health status (Ibid). 
The examination of the inequity of the socioeconomic maternal health and its disparities 
has received significant attention among researchers, there are many  studies that investigated the 
different dimension of those inequities by women's socioeconomic indicators. For that purpose, 
the WHO and World Bank recommended two indicators for tracking the level of financial risk 
protection in health which are the incidence of catastrophic health expenditure and the incidence 
of impoverishment due to out-of-pocket health payments (WHO 2007). 
Within the context of Arab countries, disparities in maternal health have been  points of 
concern among researchers for a long time. These concerns were implicitly elaborated in the 
conventional tabulation of disparities in maternal health indicators by socioeconomic status in 
reports of large surveys such as Demographic and Health Surveys. Despite major improvements 
that have occurred over the past 3 decades, several subsets of the population in most countries 
continue to face difficulties utilizing the range of health services available (Ibid). 
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MENA region 
 
The Middle East and North Africa (MENA) region of the world, includes Algeria, 
Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, 
Saudi Arabia, Syria, Tunisia, United Arab Emirates (UAE), Palestine, Somalia, Sudan and 
Yemen, consists of mostly lower-middle-income range countries in terms of gross national 
product per capita (GNP/c) but also includes the high income Gulf states at one extreme (e.g., the 
U.A.E.) and Yemen, one of the lowest-income countries in the world (UNAIDS 2011). 
The variation in health and other social indicators among countries in the region which 
based on level of economic and social development are comparable to other countries of similar 
levels of economic development (Aoyama, 2001). Further, there are significant implications on 
reproductive health given local traditions in the MENA region, which are not inextricably related 
to religion, on health, nutrition, education, and other social sectors there. The epidemiologic 
transition is taking place in most of MENA countries with an increased incidence of non-
communicable diseases, which has financial implications on the health care systems in each 
country since treatment of these diseases is more costly (Ibid). 
Interestingly one fifth of the population in the MENA region is aged 15-24, which is 
normally the age of sexual initiation, characterizing a massive youth bulge in the region (Abu-
Raddad, et al., 2010). Complex emergencies such as wars and conflicts can increase HIV 
vulnerability by decreasing access to prevention services, collapsing health infrastructure, disrupt 
social support networks and increase exposure to sexual violence as well as increase migration to 
higher HIV prevalence areas are prevalent in the region. Moreover, the MENA region has 
extensive levels of migration, displacement and mobility, and is home to the largest number of 
refugees and internally displaced persons in the world (Ibid). 
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Our work was conducted to find evidence or counterevidence for our theoretical 
assumptions as regard to the maternal, neonatal and child health outcomes and its relation to the 
different health care financing options in 21 states in the MENA region.  
MENA countries differ greatly in income level, so the validity of comparison can be a 
question. So the author used the WHO grouping system for countries based on population health 
outcomes, health system performance and the level of health expenditure into three groups in the 
Eastern Mediterranean region which is supported by the World Bank classification of MENA 
countries into low, lower middle, upper middle and high income levels. In this respect a total 
sample is better since it will allow comparison within each group(WHO 2012). We explored and 
analyzed the data of 21 countries of those classified states between 2009 and 2013 which enabled 
us to draw some conclusions and answer the research question. 
• Group 1 comprises countries where socioeconomic development has progressed 
considerably over the past decades, supported by high income (Bahrain, Kuwait, 
Oman, Qatar, Saudi Arabia, United Arab Emirates);  
• Group 2 comprises largely middle‐income countries which have developed extensive 
public health service delivery infrastructure but face resource constraints (Egypt, 
Islamic Republic of Iran, Iraq, Jordan, Lebanon, Libya, Morocco, occupied Palestinian 
territory, Syrian Arab Republic and Tunisia);  
• Group 3 comprises countries which face major constraints in improving population health 
outcomes as a result of lack of resources for health, political instability, and other 
complex development challenges (Djibouti, Somalia, South Sudan, Sudan and Yemen) 
(Ibid). 
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General Health 
 
The concerns for health equity and social determinants of health have contributed to the 
creation of evidence-based research that directs policy-makers' attention to the significance of 
health inequities and promotes policies and actions to tackle their structural and social 
determinants(WHO 2010). 
In the area of maternal health research, examination of socioeconomic maternal health 
inequities and disparities has received significant attention among researchers and numerous 
studies in the international literature have investigated various dimensions of maternal health 
inequities by women's socioeconomic indicators. These studies have repeatedly confirmed the 
strong association between women's socioeconomic status and their maternal health indicators, 
in which low socioeconomic status is significantly associated with low maternal health status and 
underutilization of maternal health care services (Ibid). 
The notion of health as a human right started to take root in the region, following trends 
that were being developed in Europe. Following the example of Great Britain, Arab countries 
that had been former British colonies principally Egypt, Iraq, Sudan and Jordan adopted the 
model of provision of medical services by the public sector financed by their treasuries (Kronfol 
NM, 2012).  
In 1964, Lebanon adopted the National Social Security Fund, demonstrating the 
commitment of the State to provide end-of-service entitlements, family support and medical 
coverage in a spirit of social solidarity between employers, employees and the State. The 
Maghreb countries Tunisia, Morocco, Algeria, and Mauritania provided services mainly through 
the public sector. Tunisia adopted a sweeping social policy, espoused by the State that ensured 
education and health for all, with support for the role of women. The Gulf countries namely 
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Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates (UAE) adopted a public 
sector welfare system financed by oil revenues. These countries had the advantage of starting 
fresh after they gained independence, since health systems prior to independence had been 
rudimentary at best (ibid). 
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Health system and reform 
 
Health systems have been defined in many different ways (Atun and Menabde, 2008; 
Shakarishvili et al., 2010). Roemer (1991) defined health systems as the combination of 
resources, organization, financing and management that culminates in the delivery of health 
services to the population. Hurst (1991), in his definition of health systems, he focused on 
financial flows and payment methods between population groups and institutions. Hsiao (2003) 
proposed to conceptualize a health system as “…a set of relationships in which the structural 
components (means) and their interactions are associated and connected to the goals the system 
desires to achieve (ends).” He limited the boundaries of a health system to the “components” that 
“…can be utilized as policy instruments to alter the outcomes.”. 
 (The World Health Report 2000) described health systems as all the activities whose 
primary purpose is to promote, restore or maintain health. This definition is the widely used one 
now. 
Universal health coverage is the basis of the WHO Twelfth General Programme of Work 
2014–2019 which includes five categories of work that collectively contribute to the 
achievement of universal health coverage: 1) Communicable diseases; 2) Non-communicable 
diseases; 3) Health through the life course which embraces maternal and child health and healthy 
ageing; 4) Health system development; and 5) Emergency preparedness. WHO emphasizes the 
fundamental importance of fair financing and financial risk protection to the achievement of 
universal health coverage with focus on the maternal and child health (WHO 2013). 
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The WHO framework (WHO, 2007) defines the health system in terms of the following 
six discrete “building blocks”: (i) Service delivery; (ii) Health workforce; (iii) Information; (iv) 
Medical products and technologies; (v) Financing; and (vi) Leadership and governance, 
corresponding to the main functions already defined in the World Health Report 2000 (WHO, 
2000), these building blocks were intended to allow a definition of the desirable attributes of a 
health system and help define WHO priorities and gaps (WHO, 2007). 
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Health financing  
 
The adoption or scaling up of demand-side financing (DSF) is actively considered as a 
way of improve access to health services in many developing countries of the world (Anwar et 
al., 2008; Behrman & James, 1998; Bhatia & Gorter, 2007; Bhatia, Yesudian, & Gorter, 
2006). The common approach for expanding access to health services has been to invest in 
supply increasing interventions such as services geographic coverage as well as the quality of 
service delivered in terms of trained staff, equipment, supplies, medications, etc. By the early 
1990s, it became clear that supply-side policies alone will not sufficiently address the low 
service utilization concerns related to the inequality (Bhatia & Gorter, 2007; Bhatia et al., 2006; 
Ensor & Cooper 2004; Koblinsky et al., 2006; Thaddeus & Maine 1994).  
Most of the public health care programs in the Arab countries provide comprehensive 
coverage of preventive, ambulatory and in-patient services. These services are normally either 
completely free of charge or received at a nominal fee. Despite differences in health system size, 
structure and financing, evidence suggests that across the region particular poor population and 
marginalized groups are affected by barriers to accessing health care disproportionately to rich 
population (Ensor T, 2004).  
The access to maternal health services is still low, especially for poor and marginalized 
groups, despite the capacity expansion of healthcare facilities. This may be due to the relatively 
high out-of pocket “OOP” expenses in both the public and private sectors which is not affordable 
by poor people (Bonu, Bhushan, Rani, & Anderson, 2009; Borghi, Sabina, Blum, Hoque, & 
Ronsmans, 2006, Borghi, Ensor, Somanathan, Lissner, & Mills, 2006; Dhar et al., 2009).  
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Despite major improvements and efforts exerted to improve the health care access over the 
past 3 decades, there are still many subsets of the population in most countries continue to face 
difficulties utilizing the range of health services available. It is feared that these difficulties may 
increase with the current trend towards a greater degree of cost-sharing and co-payment for health 
care. As per the global health expenditure,  this region spent approximately US$ 125 billion on 
health in 2011. This figure constitutes 1.8% of the total world health spending for around 8.7% 
of the world population. Almost 40% of health expenditure is being spent out-of-pocket (Global 
Health Expenditure database, 2013). 
 
The funding of health care is different from health care spending because it focuses on 
how to allocate revenues to the different expenditures of the health care sectors (Santerre & 
Neun 2000). 
 
Based on the healthcare financing analysis, Le defined public financing of health care as 
“financing via taxes and compulsory health insurance premiums” (Le 1987). Out-of-pocket 
payments are defined as health expenditures paid directly by individuals consisting of co-
payments, co-insurance, deductibles, and spending on self-medications (Calikoglu 2009). The 
private funding of health care is often negatively impacted the utilization of health care facilities 
and services.  The  out-of-pocket expenditures are not only related to the absolute amount of 
cost-sharing, it also represent a cash flow challenge since payments are often up front. In some 
cases, the overall caps on maximum cost-sharing are too high to effectively protect vulnerable 
groups (Kronfol NM, 2012). 
Financing methods for the health care services has different sources, it includes general 
taxation, social insurance, private insurance, donor funding, community financing and direct out-
of-pocket payments by patients. The profile of the health financing for a person is the mix of 
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different financing methods that determine who will bear the financial burden. Also it affected 
the decision of whether or not this person will utilize such health care service. So the way of 
allocation of the available funds for health finance is affecting individuals access to health care 
facilities and has an implication on both access and equity, so funds need to be allocated 
efficiently on different levels, geographically and also within the health care sector itself. (WHO, 
2013). 
 
Away to improve such situation related to the maternal health services utilization 
consequently achieving the Millennium Development Goal (MDG) for maternal health, the focus 
has shifted to reducing financial barriers that prevent people from access to such facilities 
(Bhatia et al., 2006). 
For achieving such purpose, there are two schemes to finance health care: General 
Taxation (GT) and Social Health Insurance (SHI). Under GT, the government provides the 
population with free health care or at a very low price. On the other hand, low and middle 
income countries have limited ability to raise sufficient funding from taxes to meet all health 
financial requirements due to the high rates of poverty and to the large size of informal economy, 
thus they can’t provide a functioning system (Witter et al., 2009). 
 
WHO suggested that there is no one best prepayment mechanism that fits all countries in 
terms of raising funds or protecting households from financial catastrophe resulting from health 
shocks (WHO, 2005). Countries are at different situations and are facing different kinds of 
challenges related to the health system strengthening and so they need to have clear decision on 
methods of funds allocation for financing the health system and how to meet the need given their 
social structure, economic challenges and political contexts, so there is no single ideal way for 
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financing the health care, however reducing the OOP portion is a key to reduce the financial 
catastrophe resulting from illness (Ke Xu et al., 2007).  
There was a study conducted by Xu et al. that explored the determinants of catastrophic 
health expenditure in 59 countries. The conclusion was that the governmental proportion as 
opposed to the OOP share of total health spending is the main factor explaining the prevalence of 
catastrophic health expenditure across the countries (Ke Xu et al., 2003). 
In Egypt the OOP became the principle mean of financing health care in Egypt. 
According to the National Health Accounts, in 2008, OOP accounted for 60% of health spending 
however public finance represented only 33.5%. The remainder is funded by donors, public firms 
and employer funds (Ministry of Health, Egypt, and Health Systems 20/20, 2010). So 
depending on the OOP in financing health care leaves households exposed to risk of financial 
failure if any of the household members become sick. Therefore, health shocks can push 
households into financial catastrophe resulting from health payments and lost earnings due to 
inability to work (Ke Xu et al.,  2003). 
 
WHO and the world bank  recommended two indicators to track the financial risk 
protection level in health, those two indicators are the incidence of impoverishment due to out of 
pocket payment and the incidence of catastrophic health expenditure. The later shows the 
number of individuals of all income levels who suffer financial hardship (spending more than 
40% of their disposable income),. While the former captures the fact that relatively small 
payments can have severe financial consequences as well, particularly for people already close to 
the poverty line (WHO 2007). 
In the absence of these two indicators, the share of out-of-pocket spending which are 
payments called direct payments made by individuals and households at the point of receiving 
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health services and which are not reimbursed by a third-party can be used as a proxy. Decreasing 
the OOP share is the aim of well-functioning inclusive health care system and support the 
universal to health care services. Evidence suggests that where the share of out-of-pocket 
payments is higher than 20% of total health expenditure, households encounter an increased risk 
of financial catastrophe and impoverishment, which undermines the timely demand and use of 
needed care (The world health report 2010). 
In respect of financial risk protection, the share of out-of-pocket payment from total 
health spending has been stable over the last decade but each group of countries has 
demonstrated diverse trends. In Group 1 countries it decreased from 21% to 17%; in Group 2, it 
fluctuated around 50%; and in Group 3, it increased from 59% to 69% (ibid). 
 
The scarcity of resources in this century is a huge challenge for all health care receivers 
particularly mothers  who really in need for those services and who may be prevented for access 
due to financial barrier, geographical barrier and other barriers . During childbirth, for example, 
attendants with the skills to respond to complications are present at only half of deliveries 
worldwide (Ibid). 
The National Health Accounts (NHA) is a framework that measures total public, private, 
and donor national health expenditures. This tool is formed in a standard set of tables. It provides 
useful information to aid in understanding the health care financing system. 
Given the importance of consistency in the methods used to measure national health 
accounts (The World Bank, 2003), for the comparison and analysis of national health 
expenditure “Public spending on health/ Out of pocket payments / financial catastrophe” along 
with the “Maternal, Neonatal and Child health outcomes” cross the three categories of MENA 
region countries. Data was selected from a single source (Countries statistics summaries sheets 
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of the WHO regional office) to ensure that comparisons is based on the same estimation and data 
collection methods; using the most recent data for the last five years. 
 
Maternal and child health outcomes 
Reproductive health and rights were established as one of the cores for the human rights 
and development during the  UN International Conference on Population and Development 
(ICPD) in Cairo in 1994 also fostered during the World Conference on Women in 1995 in 
Beijing (Aoyama, 2001).  
 
The ICPD promoted the concept of the sexual and reproductive health and rights 
“SRHR” (Aoyama, 2001; Zurayk, 2001). The Non-Governmental Organizations (NGOs) 
attended this conference agreed to a 20-year programme of action to promote sexual and 
reproductive health as well as promote the reproductive rights and stabilize the world’s 
population. ICPD displayed the importance of the linkages between population, health, poverty, 
education, patterns of production and consumption, and the environment (Glasier, Gulmezoglu, 
Schmid, Moreno, & Van Look, 2006).  
The ICPD Programme of Action proposed a definition of reproductive health as a 
complete state of physical, mental and social well-being with relation to the reproductive system 
as well as its functions and processes instead of just an absence of disease or infirmity (Aoyama, 
2001).  
According to the WHO, Sexual health refers to a complete state of physical, mental, and 
social wellbeing related to sexuality requiring a beneficial and respectful approach to sexuality 
and sexual relationships including the option to have safe and pleasurable sexual experiences 
devoid of coercion, discrimination and violence (WHO, 2012).  
23 
 
On the other hand, ICPD definition of reproductive health included sexual health, 
however, the value of sexual health as a separate issue in public health emerged for various 
reasons not limited to but including the HIV pandemic, increasing global rates of sexually 
transmitted infections (STIs) and increasing awareness of the public health significance of 
problems such as gender-based violence (GBV). These public health topics are also concerned 
with enabling safe and satisfying sexual relationships for people of all ages, including 
adolescents and those beyond the reproductive years, free of gender discrimination, disparate 
access to health services, restrictive laws, sexual coercion and exploitation and GBV (Glasier et 
al., 2006). 
In order to achieve the best outcomes in the area of maternal and child health, promote 
the sense of well-being and control over one’s life and ability to enjoy his sexual and 
reproductive health rights, consequently reducing child mortality improving maternal health, and 
combating HIV/AIDS which are three goals of the MDGs, all of those are directly linked to the 
access to such services (Fathalla & Rashad, 2006). 
So as the SRHR is linked directly to three of the MDGs, so it is considered as essential 
for the achievement of all MDGs (Glasier et al., 2006). Reproductive rights were defined during 
the 1994 ICPD as human rights based on the basic right of all couples and individuals to choose 
the number, spacing and timing of children and the resources to do this, as well as to attain the 
highest standard of reproductive and sexual health (Aoyama, 2001).  
Sexual rights also include the right of all individuals to seek, receive and deliver 
information related to SRHR, and give the ability to decide whether or not to be sexually active, 
have consensual sexual relations and marriage, and pursue a satisfying, safe and pleasurable 
sexual life (Glasier et al., 2006). 
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SRH also includes activities like family planning; prenatal care; safe delivery of babies; 
postnatal care and management of complications during pregnancy and delivery; prevention and 
management of complications related to abortion; diagnosis and treatment of reproductive tract 
infections (RTIs) and STIs including provision of HIV/AIDS; information, education and 
counseling; and discouragement of harmful practices such as female genital cutting (FGC) and 
gender-based violence (GBV) (Aoyama, 2001) as well as promotion of healthy sexuality 
(Glasier et al., 2006). 
 
Attention to maternal and child health has recently become recognized more broadly as a 
means to achieve objectives of social and economic development and stability in addition to 
positive health outcomes for women and children (Aoyama, 2001). Complications related to 
STIs and RTIs include infertility or even death in the case of HIV/AIDS (Ibid) which can affect 
productivity and quality of life.  
Improving the maternal and child health outcomes for both women and their children 
requires resources which consequently requires sufficient funding to implement proven quality 
interventions that span the continuum of care from pre-pregnancy to delivery, the postnatal 
period, and childhood. Access to health care services and utilization of such services remain 
serious concern to the health care systems of the Arab countries. It is also important to highlight 
that over the past few decades, Arab countries have witnessed marked improvements in the 
health status of their population, as evidenced by economic, social and health indicators. (UNDP 
2012)  
With the presence of these large maternal health inequities, many researchers argued that 
the achievement of Goal 5 of the Millennium Development Goals  which is the reduction of the 
maternal mortality and improve maternal health can only be materialized in some countries 
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through maternal health policies that would stand beside the poor people and enhance the access 
and utilization of maternal health care services by marginalized and vulnerable women(Ibid). 
Within the context of Arab countries, disparities in maternal health have been a point of concern, 
part of those concerns are related to the disparities in the maternal health indicators by 
socioeconomic status in reports of large surveys such as Demographic and Health Surveys 
(DHS), Pan Arab Project for Child Development (PAPCHILD), Pan Arab Project for Family 
Health (PAPFAM), and Gulf Family Health Surveys (GFHS), additionally other research studies 
and reports related to the maternal health disparities (Khader 2009). 
On the other hand, women's education was found to be the second best predictor of 
prenatal care and hospital delivery in both Tunisia and Morocco. In Tunisia, women with some 
education were 40% more likely to receive prenatal care and 46% more likely to deliver in a 
hospital compared to women with no education, while in Morocco, the effect of women's 
education was stronger as educated women were 68% more likely to receive prenatal care and 
76% more likely to deliver at a hospital than women with no education(Ibid). 
 
 Women with high educational attainment and high standard of living were 50% more 
likely to receive antenatal care and deliver in a hospital than uneducated women and those with 
low standard of living. In Oman, education was strongly related to women's use of 
contraceptives. Women with university education were found to be almost four times more likely 
to use contraceptives compared to uneducated women. Fertility was found to be lower among 
young Palestinian women (15-24 years) with secondary education or more when compared to 
other women with less education in Gaza, the West Bank, Jordan and Lebanon. In reviewing 
hospital-based caesarean sections in the Arab region and Egypt, recent studies unveiled a general 
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positive association between education and Caesarean section. Educated women were found 
more likely to undergo this surgery than less educated women (Ibid). 
However, although almost all the earlier literature has succeeded in highlighting the 
significant inequities in maternal health indicators. Recently, more international comparative 
studies exploring the maternal health equities in the Arab countries has been conducted. One of 
those studies conducted on 45 developing countries including some Arab countries, the study 
shows that Egypt, Morocco and Yemen were among the countries in which significant inequities 
by wealth quintiles denoted in some indicators mainly the attendant of birth by birth professional 
attendant also birth for which two or more antenatal visits were conducted (Ibid). 
,  
 
According to the WHO, there are three features of maternal health care mean in which 
general, insurance, or at least pre-payment, is preferred to direct user payments. Firstly, medical 
services for women during pregnancy are usually essential with potentially life-threatening 
implications if not obtained. Secondly, maternal care can often be expensive, absorbing a 
substantial fraction of a household’s disposable income which affects the total family finance 
and income. Finally, while basic delivery care is required for all women, care during 
complications is uncertain making it difficult for households to plan for the financial 
consequences. Relying on direct payment alone can mean that paying for health services can 
have catastrophic implications for the household economy. These are the key features that led 
WHO to make fairness of financing contributions based on increased pooling one of the three 
pillars of a successful health system (WHO 2010).  
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Literature review 
 
The notion of health as a human right started to take root in the region, following trends 
that were being developed in Europe. Following the example of Great Britain, Arab countries 
that had been former British colonies principally Egypt, Iraq, Sudan and Jordan adopted the 
model of provision of medical services by the public sector financed by their treasuries (Kronfol 
NM, 2012).  
In 1964, Lebanon adopted the National Social Security Fund, demonstrating the commitment of 
the State to provide end-of-service entitlements, family support and medical coverage in a spirit 
of social solidarity between employers, employees and the State. The Maghreb countries Tunisia, 
Morocco, Algeria, and Mauritania provided services mainly through the public sector. Tunisia 
adopted a sweeping social policy, espoused by the State that ensured education and health for all, 
with support for the role of women. The Gulf countries Bahrain, Kuwait, Oman, Qatar, Saudi 
Arabia and United Arab Emirates (UAE) adopted a public sector welfare system financed by oil 
revenues. These countries had the advantage of starting fresh after they gained independence, 
since health systems prior to independence had been rudimentary at best. (ibid) 
 
Previous studies show that the poor are significantly less healthy than the rich (Wagstaff, 
2000 and Gwatkin, 2000) and that the rich are more likely to obtain medical care when sick 
(Makinen et. al., 2000). Hence, it is the level of health care financing that can bridge the gap 
between the health status of the poor and the rich. For example, (Anand and Ravallion, 1993) 
using cross-sectional data for 22 developing countries in 1985 find that health expenditure raises 
life expectancy.  
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In a study on Philippines, the (The World Bank 1995) reported that public expenditure 
on health in the Philippines contributed to the reduction in infant mortality rates in the poorer 
regions, but not in the richer regions.  
In their study involving 50 developing countries, (Gupta, et al., 1999) found empirical 
evidence to support the claim that greater public spending decreased infant and child mortality 
rates. In a further study by these authors (Gupta et al., 2001) relating to public spending on 
health care for a larger sample (70 developing countries), the authors find some evidence that 
health expenditure reduces childhood mortality.  
(Hojman’s, 1996) study involving Central American and Caribbean countries revealed that 
public health spending has a statistically significant effect on health status.  
There are studies that do not find any support or statistically insignificant support for health 
expenditure reducing mortality rates. Le Grand (1987) found weak and a negative correlation 
between health inequality and share of public spending in health care. Filmer, Hammer and 
Pritchett (1998) attempted to address the issue of allocations within the health sector by 
including a measure of government spending on primary health care in their cross- section 
analysis of the causal factors of infant mortality and fail to find a statistically significant impact 
of primary health care spending on infant mortality rates.  
Filmer and Pritchetts’s (1999) further study on government health expenditure on infant and 
under five mortality rates in 98 developing countries reveal statistically insignificant effect.  
Deolalikar (2005) using a state panel for 1980-99 for India found no effect of current health 
expenditure on mortality rates. 
 
The question “does spending on health care services matter in achieving better health 
outcomes?” has received much attention in the literature. This question has been asked in both 
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developed and developing country contexts. It has been analyzed at the aggregate country level 
using cross-country datasets (Pritchett and Summers 1996; Filmer et al. 1998; Filmer and 
Pritchett 1999; Rutstein 2000; Shi 2000), at the regional level within one country (Dreze and 
Murthi 1999), and at the household level using DHS and fertility surveys (Hughes and 
Dunleavy 2000). Finally, this issue has been analyzed using a wide range of measures to capture 
health outcomes ranging from maternal and child mortality to cancer deaths. 
However, the empirical evidence on this topic is mixed. Some early evidence generated using 
developed country level data showed that spending on health care services was not associated 
with noticeable improvements in health outcomes leading to the notion that health care services 
play more of a “caring” rather than “curing” role in developed countries. “Countries that spend 
more may well buy more caring, but little additional curing” (Newhouse 1977, p. 122) 
Anderson and Poullier (1999) found that while from 1990 to 1997 US health spending per 
capita increased 4.3% per year, compared with the OECD median of 3.8%, the US was generally 
in the bottom half according to available measures and its relative place has been declining since 
1960 (Anderson and Poullier 1999; Andreson and Hussey 2001).  
Fisher et al. (2003) using US Medicare data found that patients’ health status was similar across 
five regions with different spending levels, but those who lived in high-spending regions utilized 
more health care services. They also found “no evidence of lower death rates, better functional 
status, or consistently better satisfaction with care for patients in the high-spending regions” 
(Fisher et al. 2003) 
 
On the other hand, there are studies showing a positive effect for health spending on 
health outcomes in developed countries. The study by Cremieux et al. (1999) using province 
level data showed that health care spending does matter. Cremieux et al. (1999) examined the 
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relationship between health care spending and health outcomes using province level Canadian 
data and found evidence that lower health care spending was associated with a statistically 
significant increase in infant mortality and a decrease in life expectancy in Canada controlling 
for economic, socio-demographic, nutritional and lifestyle factors, time trends and province level 
factors. More specifically they found that a 10% reduction in health care spending was 
associated with infant mortality rates higher by 0.5%among males and 0.4% among females and 
life expectancies lower by 6 months for men and 3 months for women (Cremieux et al. 1999).  
Martin et al. (2008) used programme budgeting data from 295 English Primary 
CareTrusts to examine the link between health spending and health outcomes (cancer and 
circulatory diseases). The study estimated a health expenditure equation and a health outcomes 
equation using instrumental variables. The authors found a negative effect of health spending on 
cancer and circulatory disease deaths (Martin et al. 2008). 
Empirical literature on the link between health spending and health outcomes using 
datasets that include developing countries’ data is also inconclusive. However, the general view 
in the literature based on the majority of previous studies indicates that health spending either 
plays a minor or insignificant role in improving health outcomes.  
 
Musgrove (1996) found no evidence that public spending on health has any impact on 
child mortality, which was strongly associated with income per capita instead.  
Zakir and Wunnava (1999), using a cross-sectional dataset of 117 countries (developing 
and some developed countries) for 1 year (1993), also found that government spending on health 
played a minor role in determining infant mortality rates. 
However there are studies that present different conclusions. Anand and Ravallion 
(1993) attributed “two-thirds of the elasticity of life expectancy with respect to average income 
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to the positive effect of income on public health spending.” using dataset for 22 countries for one 
year.  
Bidani and Ravallion (1997) used a random coefficients model regressing aggregate life 
expectancy and infant/perinatal mortality rates across 35 countries against data on the 
distribution of consumption per person and allowing for differential impacts of public health 
spending and primary schooling. They found that public health spending matters and concluded 
that it matters most for poor people living in these countries (Bidani and Ravallion 1997). Both 
studies have been critiqued because their results are sensitive to the small sample size used. 
The maternal and child health of women in this region requires attention. For example, 
despite implementation of family planning programs in certain countries such as Tunisia and 
Egypt, the overall population of the region is expected to double within 30 years even with the 
annual population decline of 2.3%. Increasing migration to the Gulf States in addition to 
migration from rural to urban areas within countries in this region is expected to have significant 
social and economic effects in addition to natural growth (Aoyama, 2001). 
There are high total fertility rates (TFRs) in the MENA region regardless of the income 
level of the country. Despite several significant improvements in social sectors, women’s 
wellbeing in the MENA region is still jeopardized by many health issues among which the two 
most serious are high maternal mortality and high fertility (Ibid).  
Global experience predicts an increase in the impact of STIs and adolescent reproductive 
health issues, and although the MENA region has comparatively low HIV/AIDS rates to other 
regions, these are increasing rapidly (Aoyama, 2001; Fathalla & Rashad, 2006; Shawky, 
Soliman, Kassak, Orabi, El-Khoury, & Kabore, 2009). 
 
32 
 
 According to Fathalla & Rashad (2006), countries in the WHO defined Eastern 
Mediterranean Region (EMRO) such as the Gulf States, Iraq, Jordan, and Lebanon are off track 
for most of the targets adopted by the eight MDGs that are meant to be attained by 2015 
according to the 2005 millennium project. Some countries in North Africa that are also in the 
EMRO such as Egypt, Libya, Morocco, and Tunisia are on the right track but need to speed up 
the program to achieve the goals (Fathalla & Rashad, 2006).  
 
Contraceptive use among married women between the ages of 14-49 varies widely 
between EMRO countries from 9.9% in Sudan to 63% in Lebanon and Morocco. The surveys 
used to collect these statistics do not include unmarried women for cultural reasons. None of the 
countries in the EMRO region have participated in the WHO multicenter study on sexual 
relations among young people in developing countries (Fathalla & Rashad, 2006). 
Bokhari et al. (2007) treated the variables government health expenditures and income as 
endogenous and therefore used instrumental variables (generalized method of moments—GMM- 
H2SL) to estimate the relationship between government health expenditures and health 
outcomes. They found that the elasticity of under-five mortality with respect to government 
expenditures was about 0.33 for developing countries and therefore the authors emphasized that 
even though economic growth is important for achieving better health outcomes, government 
spending on health is “just as important” (Bokhari et al. 2007).  
These studies are considered an exception to the widely held view that country level 
aggregate health spending matters very little after controlling for country’s income. 
The evidence to date is mixed and the results are inconsistent, so there is a need to gain more 
clarity about the effectiveness of investing in health care. The overwhelming majority of the 
cross-country studies (especially studies of developing countries) use cross-sectional datasets to 
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explore this question of effectiveness of health spending. However, our understanding of this 
issue would benefit greatly from using a panel dataset and adequately controlling for country 
specific effects, which has rarely been done in the literature due to the unavailability of panel 
data. In addition, this paper examines the interaction effects of health spending and government 
effectiveness. 
Finally, our study sought to identify the main characteristics of health financing systems 
in MENA region to assess any relationship with the maternal and child health outcomes and 
provide recommendations for health policy makers. 
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Research design and methodology 
 
A) Purpose and research questions 
 
The objective of this thesis is to investigate the relationship between health care financing 
systems and cross-national Maternal, Neonatal and Child health outcomes. In doing so, we used 
the most recent available data over the last five years 2009 to 2013 for 21 countries from MENA 
region exploring the three dimensions of the maternal and child health outcomes namely a) 
Infant mortality b) Maternal mortality and c) Child health.   
 
We followed the 2012 WHO classification of countries of the Region  based on the 
population health outcomes, health system performance and the level of health expenditure into 
three groups, which is supported by the World Bank classification of MENA countries into low, 
lower middle, upper middle and high income levels. In this respect a total sample will be better 
since it will allow comparison within each group.  
• Group 1 comprises countries where socioeconomic development has progressed 
considerably over the past decades, supported by high income (Bahrain, Kuwait, 
Oman, Qatar, Saudi Arabia, United Arab Emirates);  
• Group 2 comprises largely middle‐income countries which have developed extensive 
public health service delivery infrastructure but face resource constraints (Egypt, 
Islamic Republic of Iran, Iraq, Jordan, Lebanon, Libya, Morocco, occupied Palestinian 
territory, Syrian Arab Republic and Tunisia);  
• Group 3 comprises countries which face major constraints in improving population health 
outcomes as a result of lack of resources for health, political instability, and other 
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complex development challenges ( Djibouti, Somalia, South Sudan, Sudan and 
Yemen). (WHO 2012) 
  
As regard to the timeframe, the author explored and analyzed the data of those classified 
states between 2009 and 2013 which enabled him to draw some conclusions and answer the 
research question. This specific timeframe was chosen to include the most recent and still 
reliable data available, also to have recommendations that based on the recent situation analysis. 
 
B) Variables 
 
Based on the different health care financing system options and our study will utilize 
cross-country data for the selected countries for public spending on health on a per capita basis 
together with selected control variables that determine maternal and child health outcomes. 
Control variables include data from the following maternal and child health outcomes, as total 
fertility rate, contraceptive prevalence, maternal mortality ratio, antenatal care coverage, births 
attended by skilled health personnel, availability of basic essential obstetric care and availability 
of comprehensive essential obstetric care, perinatal mortality rate, prevalence of low birth weight 
and prevalence of infertility in women.  Our unified source is the WHO Eastern Mediterranean 
Region Countries statistics summaries sheets which include all data needed available for each 
country from 2009 till 2013. 
C) Data  
 
National Health Accounts (NHAs) is a globally accepted tool that essentially measures 
the “financial pulse” of national health. 
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D) Demographic data 
 
We will study the following countries based on WHO classifications into three groups, 
high income countries (Group 1), intermediate income countries (Group 2) and low income 
countries (Group 3). 
Table 1: Different groupings of the MENA countries according to WHO 
classification 
 
 
 
 
 
 
 
 
 
 
The variables that this study used include total fertility rate, contraceptive prevalence, 
maternal mortality ratio, antenatal care coverage, child and mother mortality and morbidity rates 
against some aspects of public expenditure to improve these outcomes. Those independent 
variables described against the public expenditure on health within selected countries categories 
to reflect the overall situation of maternal and child health outcomes in relation to the public 
spending.  Both correlation and linear regressions were used to investigate the links between the 
different maternal and child health outcomes and the public financial spending “dependent 
variable”. 
Regression was carried out to identify the relationships between each independent 
variable and public spending.  
Group1 Group2 Group3 
Bahrain Egypt Afghanistan 
Kuwait Iraq Djibouti 
Oman Jordan Somalia 
Qatar Lebanon S. Sudan 
Saudi Arabia Libya Sudan 
UAE Morocco Yemen 
 OPT  
 Syria  
 Tunisia  
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Significance in univariate correlation defined as r >0.2 and P<0.05 in two-sided. The 
factors that will be statistically significant in associations will be included in the multivariate 
linear regression models to identify the dominant factors which influenced by the public 
spending on health outcomes.  
The module is as below: 
OOP health expenditure = F (maternal mortality + under 5 mortality + neonatal mortality) 
 
Significance also defined as P<0.05 in 2- sided. PASW Statistic Version 18.0 (Copyright 
SPSS Inc.) used to do the analysis. 
E) Hypotheses 
 
Through this study, the researcher explored the hypothesis of whether spending more on 
health system always resulted in better outcomes, also if there any association between the 
spending and the maternal and child health outcomes? . Also our main argument is that: Can 
OOP health financing portion positively affect the maternal and child health outcomes? 
We tested this hypotheses through health financing indicators and maternal and child 
health indicators using a unified data source, and selected the indicators that enabled us to reply 
to our hypothesis. 
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Findings 
Spending more, efficiently, means better health outcomes 
 
The researcher analyzed secondary data published in NHAs for MENA region countries 
based on the WHO classifications of the countries of the region. The data collected based on the 
recent available data for each CO based on the last five years (2013-2009). 
The findings are summarized into three levels: 
1. Basic description of the data and significant differences 
2. Correlation/ Association 
3. Regression 
1. Basic description of the data and significant differences 
 
Table 21  presents a general overview of the data where we can observe the demographic 
characteristics as well as the growth trends among the different three groups of counties. It shows 
also the difference in the (mean) of the different groups as regard to the different demographic 
variables. 
 
1 All tables of this section made by the researcher and the data source is the NHAs recent data 2012 
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MCH and health financing in MENA region, number talks… 
Table 2 : Demographic characteristic of the MENA region countries 
  
General demographic data Age 
 
Area 
(KM2) 
Populat
ion in 
thousa
nds 
Crude 
birth 
rate 
(%) 
Crude 
death 
rate 
(%) 
Grow
th 
rate 
(%) 
Total 
fertility 
rate 
(/woma
n) 
% of 
population 
aged less 
than 15  
% of 
populatio
n aged  
more 
than 65 
Life 
expect
ancy 
(Yrs.) 
Group1          
Bahrain 767 1195 14.3 2.1 5.8 1.9 20.9 2.2 75.3 
Kuwait 17818 3632 16 1.5 1.8 0.9 21.2 1.9 77.7 
Oman 309500 3623 32.1 3.2 2.9 3.7 22.1 2.6 76.2 
Qatar 11607 4357 11.9 1.1 2.1 2.1 14.8 1.1 78.2 
Saudi 
Arabia 
2000000 29196 22.5 3.8 3.2 2.9 30.4 2.9 73.8 
UAE 83600 8264 9.6 0.9 6.1 2 19.1 0.9 77.4 
Mean 403882 8377.8 17.73 2.10 3.65 2.25 21.42 1.93 76.43 
          
Group 2                 
 
Egypt 1009500 83210 31.9 6.4 2.1 3 31.5 3.7 70.4 
Iraq 435052 34207 38.1 3.9 3.4 5.2 42.3 3.1 72.7 
Jordan 89318 6388 28.1 7 2.2 3.5 37.3 3.2 73 
Lebanon 10452 4104 22.2 5.6 1.7   24.6 9.6 81.5 
Libya 1665000 5922 24.9 4.1 2.8 2.7 31.1 4.2 72.3 
Morocco 710850 32597 18.5 5.1 1.1 2.6 26.6 5.9 74.8 
OPT 6020 4357 27.1 2.6 3 4.4 40.2 2.9 72.7 
Syria 185180 21639 30.8 3.8 2.5 3.5 37.2 4.1 73.1 
Tunisia 154630 10674 18.8 5.9 1.3 2.2 23.5 7 74.9 
Mean 474000.222 22566. 26.71 4.93 2.23 3.39 32.70 4.86 73.93 
          
Group3                 
 
Afghanistan 652225 26500 35.6 29.6 2.6 5.1 46 4 61 
Djibouti 23000 865 42   3.9   35.2 4.1 52.9 
Somalia 637700 8698 44 16 2.6 6.4 44.4 2.6 50 
S. Sudan 640000 8260     2.2 6.7 51 2.6 42 
Sudan 1882000 33976 29.4 17.5 2.5 3.9 42.6 5.5 59.8 
Yemen 555000 22879     3   42.4 3.2 62 
Mean 731654.167 16863 37.75 21.03 2.80 5.53 43.60 3.67 54.62 
P value   .651 .393  .002  .000  .092  .001   .000  .013 .000 
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Based on Table 2, it is clear that the crude birth rate increased significantly through 
moving from one group to another, so the means for the first, second and third groups were 
17.73, 26.71 and 37.75 respectively. 
Same also applies to the crude death rate, as it was 2.1%, 4.93% for both the first and 
second groups respectively and then increased to a high level at the third group to be more than 
21% of the whole population. 
Interestingly, it is also important to highlight that the fertility rate is high in the low 
income countries (the third group) 5.53/woman than the other two groups. On the other hand the 
life expectancy is much higher in the first group (76.43 years) than the second and higher in the 
second group than the third group. P value is > .05 
Figure 1show the mean results for the three groups as regard to the life expectancy and 
fertility rate. 
 
Figure 1 the life expectancy and the fertility rate among the three groups 
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Health financing system 
Table 3 Health financing figures among the MENA countries  
  
Health Finance 
 
GDP/Ca
pita 
Per 
capita 
total 
health 
expendit
ure 
(USD. 
PPP) 
Per 
capita 
gov. 
expendit
ure on 
health 
(USD.P
PP) 
Total 
expendi
ture on 
health 
as % of 
GDP 
Gov. 
Health 
Expendit
ure as % 
of total 
health 
Expendit
ure 
OOP 
expendit
ure as of 
% total 
health 
expendit
ure 
Gov 
health 
expendit
ure as % 
of total 
gov. 
expendit
ure 
Mo
H 
budg
et as 
% of 
gov. 
budg
et 
Group1         
Bahrain 19512 740 525 3.8 71 16.1 9.2 7.4 
Kuwait 56426 1500 1233 2.7 82.2 16.1 5.9 6.6 
Oman 25536 598 483 2.3 80.8 11.4 4.9 7.2 
Qatar 92789 1776 1396 1.9 78.6 13.6 5.8 4 
KSA 20540 758 522 3.7 68.9 18 6.8 6.8 
UAE 49005 1640 1220 3.3 74.4 16.2 8.8 8 
Mean 43968 1168.67 896.50 2.95 75.98 15.23 6.90 6.67 
Group 2 
        
Egypt 2801 137 55 4.9 40.5 58.2 6.9 4 
Iraq 3993 332 268 8.3 80.7 19.3 10.2 4.9 
Jordan 4655 392 266 8.4 67.7 24.7 17.6 6.3 
Lebanon 9904 622 159 6.3 25.5 56.5 5.8 2.6 
Libya 9063 398 274 4.4 68.8 31.2 7.9 5.7 
Morocco 3082 186 64 6 34.3 58 6.5 5.3 
OPT 1697 248 91 16 37 37 10 10 
Syria 2702 101 50 3.7 49 51 5.6 5 
Tunisia 4331 267 147 6.2 55.1 39.5 10.8 7.9 
Mean 4692.00 298.11 152.67 7.13 50.96 41.71 9.03 5.74          
Group3 
        
Afghan. 584 56 9 9.6 15.6 79.4 3.3 3.7 
Djibouti 1336 105 72 7.9 68.1 31.6 14.1 12.2 
Somalia 284 
    
55 
  
S. Sudan 1972 32 13 1.6 26.3 55.4 4 3 
Sudan 1234 104 29 8.4 28.4 69.1 10.6 6.6 
Yemen 1617 88 18 5.5 20.9 78.1 4.3 3.6 
Mean 1171.17 77.00 28.20 6.60 31.86 61.43 7.26 5.82 
P value  .000 .000 .000 .043 .001 .000 .487 .765 
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Table 3shows the diversity between the three groups as regard to many health financing 
indicators.  
For the per capita total health expenditure, it is clear that the first group is far away from 
the other two groups. P value > .01 
For the governmental expenditure, it is also clear that in the first group the governments 
contribute with high percentages toward the health related expenses with significant value 
compared to the other two groups P value > .01 
For the OOP expenditure, it is also clear that the high income countries pay less in this 
regard than the low income countries, with high significant value compared to the other two 
groups P value > .05 
Figure 2describes the full health financing indicators, and explain the relationship 
between the total expenditure as % of the GDP, also the gov. health spending also the OOP 
spending % of the total health expenditure, in comparison to the three groups that separated y 
vertical lines. It was clear that the total expenditure on health as % of GDP has no significance 
increase or decrease in between the three groups, we even find it as high at the second group 
which is the group of the best RH outcomes. When it comes to the gov health spending we find it 
high at the first group (richest countries) and then decrease to reach the minimum at the third 
group, the opposite applies to the OOP which is minimal in the first group (best RH outcomes) 
and reach maximum at the third group. This denotes that it is not aout the spending on health but 
the financing strategy that determine the best outcomes. what does the chart say, the OOP 
spending is not discussed enough earlier,  
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Figure 2 Health financing indicators among the countries of the three groups 
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Health infrastructure and resources 
 
Table 4 Health infrastructure and resources among the MENA countries  
  
Health countries resources/infrastructures  
Physicians 
/ 10000 of 
population 
Nurses / 
10000 of 
population 
Hospital beds 
/ 10000 of 
population 
Primary health 
care units / 10000 
of population 
Group1     
Bahrain 24.4 44.3 20.8 0.2 
Kuwait 27 56 22 0.2 
Oman 19.5 43.1 16.5 0.8 
Qatar 34.9 61.9 12 2 
Saudi Arabia 24.5 47.8 20.9 0.8 
UAE 14.7 26 10.7 2.6 
Mean 24.17 46.52 17.15 1.10 
Group 2 
    
Egypt 7.7 13.8 5.2 0.6 
Iraq 8.4 16.3 13 0.7 
Jordan 27.1 46.6 18 2.4 
Lebanon 36.5 29.1 34.5 2.3 
Libya 20 71 37 2.6 
Morocco 6.1 9 8.5 0.8 
OPT 20.2 19.7 13 1.8 
Syria 6.5 15 15.3 1 
Tunisia 12.8 32.5 21.2 2 
Mean 16.14 28.11 18.41 1.58 
Group3 
    
Afghanistan 2.9 3.6 5.3 1 
Djibouti 2.1 5.1 14.2 0.5 
Somalia 0.3 0.8 
 
4.8 
South Sudan 0.2 0.2 
  
Sudan 3.7 10 8.2 1 
Yemen 3 7.2 7.2 1.6 
Mean 2.03 4.48 8.73 1.78 
P value 
between the 3 
groups 
.001 .000 .175 .592 
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Away from the clear difference between figures of physicians and nurses among the three 
groups, the coverage of the primary health unit is the most important as one of the global health 
related indicator. There is a significant P value > .05 when comparing the three groups. 
Maternal and Child Health 
 
 For the maternal and child health, the author selected specific variables that determine 
the maternal and child health outcomes. Variables for the maternal health are, the contraceptive 
prevalence, the antenatal care coverage, the percentage of birth attended by skilled health 
personnel. For the child health we selected, the new birth with low birth weight and also 
underweight children. We compared those indicators  cross the three categories to find any 
differences between the three groups in relation to those indicators. 
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Table 5 Maternal and child health figures among the MENA countries  
  
Maternal and Child Health 
 
Contraceptive 
prevalence 
(%) 
Antenatal 
care 
coverage 
(%) 
Birth attended 
by skilled 
health 
personnel (%) 
New birth 
with low 
birth weight 
(%) 
Underwei
ght 
children 
(%) 
Group1      
Bahrain 
 
100 99 10 
 
Kuwait 
 
100 100 8.3 
 
Oman 24 99 99 11.1 4.6 
Qatar 36 100 100 7.9 
 
Saudi Arabia 
 
98 97 7.5 
 
UAE 37 100 100 3.2 
 
Mean 32.33 99.50 99.17 8.00 4.60       
Group 2 
     
Egypt 44 57 95 6 6 
Iraq 53 51 87 5.9 8 
Jordan 61 99 100 7 3 
Lebanon 54 95 96 11.5 
 
Libya 46 93 100 4 4.8 
Morocco 57 77 73.6 8 3.1 
OPT 38 100 100 7.6 3.7 
Syria 38 88 96 10.3 10.3 
Tunisia 63 96 99 8.2 3 
Mean 50.44 84.00 94.07 7.61 5.24       
Group3 
     
Afghanistan 15 60 34 6 
 
Djibouti 13 73 56 20 28.9 
Somalia 15 26 33 5 36 
South Sudan 2 17 19 
 
12.5 
Sudan 7 74 73 31 32.2 
Yemen 
 
47 36 32 
 
Mean 10.40 49.50 41.83 18.80 27.40 
P value 
between the 3 
groups 
.000 .000 .000 .018 .000 
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However the contraceptive prevalence is higher among the second group even more than 
the first group, but this may be attributed to the large population number of this group compared 
to the other two groups. On the other hand, the prevalence is the lowest at the third group. 
 
For the Antenatal care coverage which is one of the most important maternal health 
indicators. As from the above tables, it showed that the coverage is 99.5, 84 and 49.5 for the 
three groups respectively. It was clear that there was a significant difference between means of 
the three groups with P value of > .01 “highly significant” 
 
Same applied to the birth attended by skilled health personnel among the three groups; it 
was 99.17, 94.07 and 41.83 for the three groups respectively with no statistical significant 
relationship, P value <.05 
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Figure 3 Maternal Health figures among the countries of the three groups 
 
 
Neonatal and Child mortality 
 
For the neonatal and child mortality, the author selected specific variables that determine 
that health outcome. Variables are, the neonatal mortality rate (per 1000 live birth), the infant 
mortality rate (per 1000 live birth) and the under-five mortality rate (per 1000 live birth). We 
compared those indicators  cross the three categories to find any differences between the three 
groups in relation to those indicators. 
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Table 6 Neonatal and child mortality figures among the MENA countries  
  
Neonatal and Child mortality  
Neonatal 
mortality (per 
1000 live births) 
Infant 
mortality(per 
1000 live births) 
Under 5 mortality 
(per 1000 live 
births) 
Group1    
Bahrain 3.6 8.2 9.6 
Kuwait 5.5 9.5 11 
Oman 6.7 10 11.6 
Qatar 3.9 6.3 7.4 
Saudi Arabia 5.2 7.4 8.6 
UAE 5 7.2 8.4 
Mean 4.98 8.10 9.43     
Group 2 
   
Egypt 11.8 17.9 21 
Iraq 19 28.4 34.4 
Jordan 11.5 16.4 19.1 
Lebanon 5.4 8 9.3 
Libya 9.4 13.2 15.4 
Morocco 17.8 26.8 31.1 
OPT 12.8 19.2 22.6 
Syria 8.5 12.3 15.1 
Tunisia 9.5 13.8 16.1 
Mean 11.74 17.33 20.46     
Group3 
   
Afghanistan 36 71 98.5 
Djibouti 31.4 65.7 80.9 
Somalia 45.7 90.8 147.4 
South Sudan 35.7 66.7 104 
Sudan 28.6 49.3 73.1 
Yemen 27 46.3 60 
Mean 34.07 64.97 93.98 
P value 
between  
.000 .000 .000 
 
For the neonatal mortality which is one of the most important child health indicators. As 
from the above tables, it showed that the average neonatal mortality rates are 4.98, 11.74 and 
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34.07 for the three groups respectively. It was clear that there was a significant difference 
between means of the three groups with P value of > .01 “highly significant” 
 Same applied to the infant mortality, and under five mortality rates among the three 
groups; with statistical significant relationship, P value >.05 
Figure 4shows the relationship between the three groups as regard to the neonatal and 
child mortality 
 
Figure 4 Neonatal, Infant and under five mortality rates among the countries of the three groups 
 
 
 
 
After finalization of data description, we will move to find relationships between 
different variables. 
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Correlations between financial and health indicator  
 
Table 7 Correlation between the three categories and the demographic health indicators among the MENA countries  
 
    
Crude_bi
rth_rate_ 
Crude_dea
th_rate_ 
Total_fertility_rate_per
_woman 
Life_expectency
_years 
Cat Pearson 
Correlation 
.737** .804** .765** -.808-** 
Sig.  .000 .000 .000 .000 
(2-tailed) Sig. Sig. Sig. Sig. 
 
Table 7 shows that there is a significant correlation between the countries categories and 
the demographic health indicators among those countries. On the other hand, there was also a 
significant correlations between the main financial indicator (OOP) and those demographic 
health indicators as shown in Table 8 
Table 8 Correlation between the financial and the demographic health indicators among the MENA countries  
 
    
Crude_bi
rth_rate_ 
Crude_dea
th_rate_ 
Total_fertility_rate_per
_woman 
Life_expectency
_years 
OOP Pearson 
Correlation 
.397 .759** .502* -.500-* 
Sig.  .092 .000 .034 .021 
(2-tailed) Non Sig. Sig. Sig. Sig. 
 
 
Table 9shows that there is a significant correlation between the countries categories and 
the main financial health indicators including the OOP and the per capta total health expenditure 
among those countries.  
Table 9 Correlation between the countries categories and the financial health indicators among the MENA countries  
    Per_capita_
total_health
_expenditur
e_USD 
Per_capit
a_gov#_
expendit
ure_on_h
ealth_US
D 
Total_exp
enditure_o
n_health_a
s__of_GD
P 
Gov#_Hea
lth_Expen
diture_as_
_of_total_
health_Ex
penduture 
OOP_ex
penditure
_as_of__
total_hea
lth_expe
nditure 
Gov_health
_expenditur
e_as__of_to
tal_gov#_ex
penditure 
MoH_bu
dget_as_
_of_gov
#_budget 
Cat Pearson 
Correlation 
-.787-** -.774-** .429 -.732-** .805** .055 -.141 
Sig.  .000 .000 .059 .000 .000 .816 .555 
(2-tailed) Sig. Sig. Non Sig. Sig. Sig. Non Sig. Non Sig. 
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As the OOP expenditure can be considered as the main financial health indicators as per 
the (WHO 2007), the results show that there was also a significant correlations between the main 
financial indicator (OOP) and the other financial health indicators as shown in Table 10 
 
Table 10 Correlation between the financial and the demographic health indicators among the MENA countries  
 
 
 
 
 
 
Table 11 Correlation between the countries categories and Maternal and child health indicators among the MENA 
countries  
 
    Physic
ians__
10000
_of_p
opulat
ion 
Nurse
s__10
000_
of_po
pulati
on 
Contra
ceptiv
e_prev
alence
_ 
Anten
atal_c
are_c
overa
ge_ 
Birth_att
ended_b
y_skille
d_health
_person
nel_ 
New_b
orth_w
ith_lo
w_birt
h_weig
ht_ 
Und
erw
eigh
t_ch
ildre
n_ 
Neonata
l_morta
lity_per
_1000_l
ive_birt
hs 
Infant_
mortali
typer_
1000_l
ive_bir
ths 
Under_
5_mort
ality_pe
r_1000
_live_bi
rths 
Cat Pearson 
Correlation 
-.743-
** 
-.754-
** 
-.532-
* 
-.744-
** 
-.806-** .490* .796
** 
.886** .855** .822** 
Sig.  .000 .000 .028 .000 .000 .028 .001 .000 .000 .000 
(2-tailed) Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. 
 
Table 11 shows that there is a significant correlation between the countries categories and 
all the maternal and child health outcomes. On the other hand, there was also a significant 
correlations between the main financial indicator (OOP) and those demographic health indicators 
as shown in  
Table 12 
    Cat Per_capita_to
tal_health_ex
penditure_US
D 
Per_capita_go
v#_expenditur
e_on_health_U
SD 
Gov#_Health_Ex
penditure_as__of
_total_health_Exp
enduture 
MoH_bu
dget_as_
_of_gov
#_budget 
OOP_expendit
ure_as_of__tot
al_health_exp
enditure 
Pearson 
Correlation 
.805** -.672-** -.703-** -.949-** -.453-* 
Sig.  .000 .001 .001 .000 .045 
(2-tailed)  Sig.  Sig.  Sig.  Sig.  Sig. 
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Table 12 Correlation between the financial and Maternal and child health indicators among the MENA countries  
 
    Physi
cians
__10
000_
of_po
pulati
on 
Nurses
__100
00_of_
popula
tion 
Con
trac
epti
ve_
prev
alen
ce_ 
Anten
atal_c
are_co
verage
_ 
Birth_a
ttended
_by_ski
lled_he
alth_pe
rsonnel
_ 
New_
borth_
with_l
ow_bi
rth_w
eight_ 
Under
weigh
t_chil
dren_ 
Neonat
al_mor
tality_
per_10
00_liv
e_birth
s 
Infant
_mort
alityp
er_10
00_liv
e_birt
hs 
Under
_5_mo
rtality_
per_10
00_liv
e_birth
s 
OOP_ex
penditur
e_as_of_
_total_h
ealth_ex
penditur
e 
Pearson 
Correlation 
-.606-
** 
-.711-
** 
-
.308 
-.592-
** 
-.659-** .449* .414 .637** .595** .578** 
Sig.  .004 .000 .229 .005 .001 .047 .159 .002 .004 .006 
(2-tailed) Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. Sig. 
 
Regression between other variables 
 
Table 13A Regression between the financial and Maternal and child health indicators among the three groups in 
MENA countries  
 
 
Model Summary 
Model R R Square Adjusted R Square Std. Error of the Estimate 
1 .633a .401 .288 26.84066 
a. Predictors: (Constant), 
Gov#_Health_Expenditure_as__of_total_health_Expenduture, GDPCapita, 
OOP_expenditure_as_of__total_health_expenditure 
 
ANOVA b 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 7709.352 3 2569.784 3.567 .038a 
Residual 11526.736 16 720.421   
Total 19236.088 19    
a. Predictors: (Constant), 
Gov#_Health_Expenditure_as__of_total_health_Expenduture, GDPCapita, 
OOP_expenditure_as_of__total_health_expenditure 
b. Dependent Variable: Under_5_mortality_per_1000_live_births 
 
Coefficients a 
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Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -8.437- 79.418  -.106- .917 
GDPCapita .000 .000 -.128- -.534- .600 
OOP_expenditure_as_of__tota
l_health_expenditure 
.919 .885 .651 1.039 .314 
Gov#_Health_Expenditure_as_
_of_total_health_Expenduture 
.150 .852 .109 .177 .862 
a. Dependent Variable: Under_5_mortality_per_1000_live_births 
 
 
When we run the regression between the Under5 mortality rate as dependent variable and 
the main financial indicators, OOP, GDP, Gov health expenditure as independent factors, Table 
13 A shows that there is a significant relationship  between the main financial indicators and the 
maternal and child health outcomes. 
The module is as below: 
under 5 mortality = F (OOP health expenditure + Gov. health expenditure + GDP Capita) 
 
Same also applies to the neonatal mortality rate, so when we run the regression between 
the neonatal mortality rate as dependent variable and the main financial indicators, OOP, GDP, 
Gov health expenditure as independent factors, Table 13 B shows that there is a significant 
relationship  between the main financial indicators and the maternal and child health outcomes. 
Table 14B Regression between the financial and Maternal and child health indicators among the three groups in 
MENA countries  
Model Summary 
Model 
R R Square Adjusted R Square Std. Error of the Estimate 
1 .690a .476 .378 8.71615 
a. Predictors: (Constant), Gov#_Health_Expenditure_as__of_total_health_Expenduture, GDPCapita, 
OOP_expenditure_as_of__total_health_expenditure 
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ANOVA b 
Model Sum of Squares df 
Mean 
Square F Sig. 
1 Regression 1105.785 3 368.595 4.852 .014a 
Residual 1215.541 16 75.971   
Total 2321.326 19    
a. Predictors: (Constant), Gov#_Health_Expenditure_as__of_total_health_Expenduture, 
GDPCapita, OOP_expenditure_as_of__total_health_expenditure 
b. Dependent Variable: Neonatal_mortality_per_1000_live_births 
 
Coefficientsa 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) -7.217- 25.790  -.280- .783 
GDPCapita .000 .000 -.218- -.971- .346 
OOP_expenditure_as_of
__total_health_expendit
ure 
.402 .287 .820 1.400 .181 
Gov#_Health_Expendit
ure_as__of_total_health
_Expenduture 
.145 .277 .303 .525 .607 
a. Dependent Variable: Neonatal_mortality_per_1000_live_births 
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Conclusion and policy implications 
 
This study explored the relationship between the different health care financing options 
cross the Middle East and North Africa “MENA” countries and the maternal and child health 
outcomes of people among those countries.  
 
Our findings showed that there was a clear difference between the three countries groups 
in many areas of comparisons, those areas include the demographic characteristics, health 
financing system, health infrastructure and resources, maternal and child health and neonatal and 
child mortality. There was a significant relationship between the three groups and many 
indicators among those five thematic areas. 
In conducting the correlation between the health financing indicators and maternal and 
child health indicators, there was significant correlation between those two groups either 
negatively or positively. The most significant relationships that reply directly to our research 
question were the correlation between the total health expenses and both (, neonatal mortality, 
maternal mortality and under 5 mortality), also significant correlation between OOP expenditure 
and both (crude birth rate, crude death rate, neonatal mortality, maternal mortality and under 5 
mortality). 
 
 Our findings indicate that spending on health is significantly  associated with improving 
the maternal and child health outcomes, and reduces infant and child mortality based on the 
significant correlations between those variables. Our results also indicate that improvements in 
government effectiveness enhance the effect of government health spending which resulted in 
lowering the infant and under-five child mortality. Thus, increasing government expenditures is 
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likely to lead to better improvements of health outcomes if it is accompanied by the right policies 
and institutions, which was the case of the first group of countries in MENA region. 
The same also applied for OOP expenditure. There was significant negative correlation 
between OOP and the maternal and child health indicators. This can give a recommendation to 
policy makers to minimize this OOP portion, as with minimization of this portion lead to better 
maternal and child health outcomes. 
Therefore, there is always potential for specific health financing allocation that can point 
the efficiency of health spending and in turn increasing the effectiveness of health spending 
beyond the levels estimated in this study. The in-depth analysis of one group of countries over a 
time period taking into consideration the composition of health spending can be relevant topic 
for future research. 
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